Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance

Title
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance
Authors
Keywords
Lung cancer, EGFR, T790M, EGFR, C797S, Resistance mechanisms, Osimertinib
Journal
Journal of Thoracic Oncology
Volume 12, Issue 11, Pages 1723-1727
Publisher
Elsevier BV
Online
2017-06-27
DOI
10.1016/j.jtho.2017.06.017

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now